🔎 Trials Near Me

Home › T-Cell Lymphoma › Illinois › Chicago

T-Cell Lymphoma clinical trials in Chicago, IL

6 studies for T-Cell Lymphoma are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

RecruitingPhase 3
  • North Western University Robert H. Lurie Comprehensive Cancer Center RHLCCC, Chicago
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06561048

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

RecruitingPhase 2
  • Northwestern University, Chicago
  • University of Illinois, Chicago
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT04803201

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

RecruitingPhase 1/2
  • University of Chicago Medical Center, Chicago
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT04104776

A Registry for People With T-cell Lymphoma

RecruitingObservational study
  • Northwestern Medicine (Data Collection), Chicago
All ages · All sexes · Updated May 20, 2026 · NCT05978141

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

RecruitingPhase 1
  • Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago
Ages 18 and older · All sexes · Updated Sep 22, 2025 · NCT04234048

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RecruitingPhase 1
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770

T-Cell Lymphoma trials in other cities

Other studies in Chicago

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.